Pharmaceutical

Filter

Current filters:

None

Popular Filters

1 to 25 of 7140 results

ALK Abello files for European approval for its dust mite allergy sublingual tablets

ALK Abello files for European approval for its dust mite allergy sublingual tablets

20-11-2014

Denmark-based allergy specialist ALK Abello has filed a registration application for its house dust mite…

ALK AbelloDenmarkImmunologicalsPharmaceuticalRegulation

Mallinckrodt 4th-qtr sales and earnings beat analysts’ expectations

20-11-2014

US drugmaker Mallinckrodt has reported a strong set of financial results for the fourth-quarter and full…

FinancialMallinckrodtPharmaceutical

HHS and NIH take steps to enhance clinical trial results transparency

20-11-2014

The US Department of Health and Human Services today issued a Notice of Proposed Rulemaking (NPRM), which…

PharmaceuticalRegulationResearchUSA

Shire to relocate 500 employees in formation of new hub in Lexington, Massachusetts

Shire to relocate 500 employees in formation of new hub in Lexington, Massachusetts

19-11-2014

Following AbbVie’s recent abandonment of a $53 billion takeover offer, Ireland-headquartered drugmaker…

Business FinancePharmaceuticalPunctuationShireUSA

Valeant admits disappointment at loss of takeover target Allergan to Actavis

Valeant admits disappointment at loss of takeover target Allergan to Actavis

19-11-2014

Canadian drugmaker Valeant International has admitted that the loss of hostile takeover target Allergan…

ActavisAllerganCanadaMergers & AcquisitionsPharmaceuticalValeant

Despite patent cliffs, pharma market shows signs of stability

19-11-2014

The pharmaceutical market is beginning to show signs of stability, with a review of 30 leading companies…

Biogen IdecBoehringer IngelheimFinancialJohnson & JohnsonPatentsPfizerPharmaceutical

UK diabetes patients being denied vital prescriptions for testing strips

19-11-2014

Patients in Britain with diabetes are missing out on vital prescriptions that let them keep tabs on their…

DiabetesHealthcarePharmaceuticalUK

Threat or promise by 2020? The FT Global Pharmaceutical and Biotechnology Conference 2014

Threat or promise by 2020? The FT Global Pharmaceutical and Biotechnology Conference 2014

19-11-2014

The Pharma Letter reports from the FT Global Pharmaceutical and Biotechnology Conference 2014.

FT Global PharmaceuticalMarkets & MarketingPharmaceuticalResearchUK

Cost of bringing new drug to market now around $2.6 billion, says Tufts CSDD

19-11-2014

Developing a new prescription medicine that gains marketing approval, a process often lasting longer…

FinancialGlobalPharmaceuticalResearch

UK Patent Box changes require urgent clarification, says Withers & Rogers

19-11-2014

Last month, Treasury Minister David Gauke gave a robust defence of the UK's Patent Box scheme, which…

FinancialPatentsPharmaceuticalPoliticsUK

Added benefit of Jardiance not proven, says IQWiG

19-11-2014

Following an examination as to whether Jardiance (empagliflozin) offers an added benefit over appropriate…

Boehringer IngelheimDiabetesEli LillyGermanyJardiancePharmaceuticalPricingRegulation

Ricerca Biosciences sells out to equity investment group

19-11-2014

After conducting a thorough process to evaluate strategic acquisition offers for the company, the Ricerca…

Mergers & AcquisitionsPharmaceuticalResearchRicerca Biosciences

NICE seeks more information on Xolair to treat hives

19-11-2014

UK health costs watchdog the National Institute for Health and Care Excellence (NICE) is calling on Swiss…

DermatologicalsNovartisPharmaceuticalPricingRegulationUKXolair

Stronger punishments for production and sale of fake drugs in China

18-11-2014

Chinese authorities will hand out harsher punishment for the production and sale of fake and substandard…

ChinaMarkets & MarketingPharmaceuticalProductionRegulation

Medicines Australia welcomes new trade agreement with China

18-11-2014

Australia yesterday signed the Free Trade Agreement with China, after nearly 10 years of negotiations,…

AustraliaChinaFinancialMarkets & MarketingPharmaceuticalPolitics

Novartis’ LCZ696 reduces the risk of dying and hospitalizations

Novartis’ LCZ696 reduces the risk of dying and hospitalizations

18-11-2014

New data on Swiss drug major Novartis’ investigational medicine LCZ696, for patients with heart failure…

Cardio-vascularLCZ696NovartisPharmaceuticalResearchSwitzerland

Ablynx appoints ex-GSK director Johan Heylen as chief commercial officer

Ablynx appoints ex-GSK director Johan Heylen as chief commercial officer

18-11-2014

Belgian drug developer Ablynx has announced the appointment of Johan Heylen as chief commercial officer.

AblynxBelgiumBoardroomJohan HeylenPharmaceuticalVrije Universiteit Brussel

AstraZeneca reinforces target of $45 billion revenues by 2023

AstraZeneca reinforces target of $45 billion revenues by 2023

18-11-2014

Anglo-Swedish pharma major AstraZeneca today provided an update for institutional investors and financial…

AstraZenecaCardio-vascularFinancialInflammatory diseasesMetabolicsOncologyPharmaceuticalRespiratory and PulmonaryUK

Merck & Co’s LDL-lowering drug Vytorin meets study endpoints

Merck & Co’s LDL-lowering drug Vytorin meets study endpoints

18-11-2014

Pharma giant Merck & Co has announced that the study investigating LDL-cholesterol-lowering drug Vytorin…

Cardio-vascularMerck & CoPharmaceuticalResearchUSAVytorinZetia

Russian government to start checks for GMP compliance of domestic drug producers

Russian government to start checks for GMP compliance of domestic drug producers

18-11-2014

The Russian government plans to start massive checks of the domestic producers of drugs, as well as drug…

PharmaceuticalProductionRegulationRussiaRussian government

European Union's response to Ebola emergency

18-11-2014

West Africa is currently facing the largest and most complex Ebola epidemic on record. Guinea, Liberia…

Anti-viralsFinancialPharmaceuticalResearchRest of the WorldTropical diseases

1 to 25 of 7140 results

Back to top